Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- Check2 days agoChange DetectedRemoved the site-wide government funding status notice at the bottom of the page, with no impact on the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedResults First Submitted/Posted date updated to 2025-07-22 along with related QC update dates; no changes to the study design, primary outcomes, or eligibility criteria were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoChange DetectedThe study location in Valle del Cauca, Colombia was updated from 'Santiago de Cali, Valle del Cauca Department, Colombia, 760032' to 'Cali, Valle del Cauca Department, Colombia, 760032'.SummaryDifference0.0%

- Check45 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check53 days agoChange Detected- Added Revision: v3.1.0. - Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older Revision: v3.0.2. The page now updates its version and omits multiple drug-safety-related topics.SummaryDifference0.2%

- Check67 days agoChange DetectedUpdated revision to v3.0.2 and removed 'Back to Top'; overall a minor UI/metadata change with no impact on core content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.